Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy
Clinical trial NCT01755767 · COMPLETED
Trial details
- NCT number
- NCT01755767
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-27
- Primary completion
- 2017-03-28
- Enrollment
- 383
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.